AKBA logo

Akebia Therapeutics, Inc. (AKBA) Retained Earnings

Annual Retained Earnings:

-$1.68B-$69.41M(-4.31%)
December 31, 2024

Summary

  • As of today, AKBA annual retained earnings is -$1.68 billion, with the most recent change of -$69.41 million (-4.31%) on December 31, 2024.
  • During the last 3 years, AKBA annual retained earnings has fallen by -$215.56 million (-14.74%).
  • AKBA annual retained earnings is now -3382.66% below its all-time high of -$48.19 million, reached on December 1, 2011.

Performance

AKBA Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

Quarterly Retained Earnings:

-$1.67B+$247.00K(+0.01%)
June 1, 2025

Summary

  • As of today, AKBA quarterly retained earnings is -$1.67 billion, with the most recent change of +$247.00 thousand (+0.01%) on June 1, 2025.
  • Over the past year, AKBA quarterly retained earnings has dropped by -$36.48 million (-2.23%).
  • AKBA quarterly retained earnings is now -2705.93% below its all-time high of -$59.59 million, reached on December 1, 2012.

Performance

AKBA Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

AKBA Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-4.3%-2.2%
3Y3 Years-14.7%-11.9%
5Y5 Years-111.4%-62.2%

AKBA Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-14.7%at low-8.2%+0.4%
5Y5-Year-111.4%at low-53.3%+0.4%
All-TimeAll-Time-3382.7%at low-2705.9%+0.4%

AKBA Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.67B(+0.0%)
Mar 2025
-
-$1.67B(+0.4%)
Dec 2024
-$1.68B(-4.3%)
-$1.68B(-1.4%)
Sep 2024
-
-$1.66B(-1.2%)
Jun 2024
-
-$1.64B(-0.5%)
Mar 2024
-
-$1.63B(-1.1%)
Dec 2023
-$1.61B(-3.3%)
-$1.61B(+0.0%)
Sep 2023
-
-$1.61B(-0.9%)
Jun 2023
-
-$1.60B(-1.0%)
Mar 2023
-
-$1.58B(-1.4%)
Dec 2022
-$1.56B(-6.4%)
-$1.56B(-0.8%)
Sep 2022
-
-$1.55B(-3.5%)
Jun 2022
-
-$1.49B(+1.9%)
Mar 2022
-
-$1.52B(-4.1%)
Dec 2021
-$1.46B(-24.2%)
-$1.46B(-5.3%)
Sep 2021
-
-$1.39B(-4.5%)
Jun 2021
-
-$1.33B(-6.7%)
Mar 2021
-
-$1.25B(-5.9%)
Dec 2020
-$1.18B(-48.3%)
-$1.18B(-8.0%)
Sep 2020
-
-$1.09B(-5.8%)
Jun 2020
-
-$1.03B(-20.6%)
Mar 2020
-
-$854.80M(-7.7%)
Dec 2019
-$794.05M
-$794.05M(-13.5%)
Sep 2019
-
-$699.57M(-8.5%)
Jun 2019
-
-$644.99M(-9.9%)
DateAnnualQuarterly
Mar 2019
-
-$586.82M(-14.1%)
Dec 2018
-$514.39M(-38.7%)
-$514.39M(-13.2%)
Sep 2018
-
-$454.34M(-6.1%)
Jun 2018
-
-$428.29M(-8.6%)
Mar 2018
-
-$394.23M(-6.3%)
Dec 2017
-$370.81M(-24.8%)
-$370.81M(+4.0%)
Sep 2017
-
-$386.33M(-6.4%)
Jun 2017
-
-$363.20M(-6.3%)
Mar 2017
-
-$341.68M(-15.0%)
Dec 2016
-$297.14M(-84.1%)
-$297.14M(-14.6%)
Sep 2016
-
-$259.27M(-16.3%)
Jun 2016
-
-$222.97M(-19.1%)
Mar 2016
-
-$187.19M(-16.0%)
Dec 2015
-$161.39M(-60.3%)
-$161.39M(-14.0%)
Sep 2015
-
-$141.53M(-16.0%)
Jun 2015
-
-$122.06M(-9.6%)
Mar 2015
-
-$111.37M(-10.6%)
Dec 2014
-$100.67M(+20.8%)
-$100.67M(-11.5%)
Sep 2014
-
-$90.30M(-11.5%)
Jun 2014
-
-$80.95M(-10.4%)
Mar 2014
-
-$73.34M(+42.3%)
Dec 2013
-$127.07M(-113.3%)
-$127.07M(-113.3%)
Dec 2012
-$59.59M(-23.6%)
-
Dec 2012
-
-$59.59M
Dec 2011
-$48.19M
-

FAQ

  • What is Akebia Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Akebia Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of AKBA is -$1.68B

What is the all-time high annual retained earnings for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual retained earnings is -$48.19M

What is Akebia Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, AKBA annual retained earnings has changed by -$69.41M (-4.31%)

What is Akebia Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of AKBA is -$1.67B

What is the all-time high quarterly retained earnings for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly retained earnings is -$59.59M

What is Akebia Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, AKBA quarterly retained earnings has changed by -$36.48M (-2.23%)
On this page